Announcements Trials
Browse Landscape

Status

Completed 9Withdrawn 2Unknown 2Terminated 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 2Fatigue 1

Interventions

Paclitaxel 31Cyclophosphamide 25Trastuzumab 23Doxorubicin 17Docetaxel 15Carboplatin 15pembrolizumab 13Radiotherapy 11Letrozole 11Capecitabine 11exemestane 10Fulvestrant 10Magnetic Resonance Spectroscopy 8Lapatinib 8Biopsy 8eribulin 7abemaciclib 7Taxes 7Bevacizumab 7Anastrozole 7pertuzumab 6palbociclib 6Neoadjuvant Therapy 6Goserelin 6Drug Therapy 6Aromatase Inhibitors 6130-nm albumin-bound paclitaxel 6Therapeutics 5Saline Solution 5Radiosurgery 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Reverse Transcriptase Polymerase Chain Reaction × Breast × Clear all
NCT00898573 2015-10-02

Lapatinib Resistance in Patients With Breast Cancer

Case Comprehensive Cancer Center

Withdrawn
Breast

Breast Neoplasms

NCT00914043 2013-01-11

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

NSABP Foundation Inc

Withdrawn
Breast

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡